United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2018_register
executive
2018-05-15
article
Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments
Notices
D09002ee1bdb8ea2f
D09002ee1bdb8eac6
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
Food and Drug Administration
originator
org
United States Government Agency or Subagency
The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee. The general function of the committee is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.
83 FR 22496
https://www.govinfo.gov/app/details/FR-2018-05-15/2018-10337
2018-10337
fr15my18-66
4164-01-P
Docket No. FDA-2018-N-1577
https://www.govinfo.gov/app/details/FR-2018-05-15/2018-10337
https://www.govinfo.gov/content/pkg/FR-2018-05-15/html/2018-10337.htm
https://www.govinfo.gov/content/pkg/FR-2018-05-15/pdf/2018-10337.pdf
2 p.
22496
22497
83 FR 22496
Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments; Federal Register Vol. 83, Issue
NOTICE
2018-10337
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
2018-06-20
Docket No. FDA-2018-N-1577
4164-01-P
2018-10337
Notice; establishment of a public docket; request for comments.
The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee. The general function of the committee is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.
The meeting will be held on June 20, 2018, from 8 a.m. to 4:30 p.m.
Lauren D. Tesh, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 31, Rm. 2417, Silver Spring, MD 20993-0002, 301- 796-9001, Fax: 301-847-8533, email: ODAC@fda.hhs.gov; or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area). A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the FDA's website at https://www.fda.gov/AdvisoryCommittees/default.htm and scroll down to the appropriate advisory committee meeting link, or call the advisory committee information line to learn about possible modifications before coming to the meeting.
Meetings:
Pediatric Oncology Subcommittee of Oncologic Drugs Advisory Committee
,
fdaoma@fda.hhs.gov
ODAC@fda.hhs.gov
https://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm
https://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm408555.htm
https://www.fda.gov/AdvisoryCommittees/Calendar/default.htm
https://www.fda.gov/AdvisoryCommittees/default.htm
https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf
https://www.regulations.gov
Federal Register
Vol. 83, no. 94
Office of the Federal Register, National Archives and Records Administration
2018-05-15
continuing
daily
deposited
born digital
248 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2018-05-15
P0b002ee19a428be2
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr15my18
https://www.govinfo.gov/app/details/FR-2018-05-15
https://www.govinfo.gov/content/pkg/FR-2018-05-15/pdf/FR-2018-05-15.pdf
https://www.govinfo.gov/content/pkg/FR-2018-05-15/xml/FR-2018-05-15.xml
fdlp
22347
22585
DGPO
2018-05-15
2023-04-28
FR-2018-05-15
machine generated
eng
FR
FR-2018-05-15
83
94